| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 01/14/2015 | CN104274866A 持续释放药物载体组合物 Sustained release pharmaceutical carrier composition |
| 01/14/2015 | CN104274831A 一种基于天然衍生肽和炎症抑制剂和/或抗氧化化合物的组合物 Based on a combination of natural and inflammation-derived peptide inhibitor and / or antioxidant compounds |
| 01/14/2015 | CN104274457A 一种组合物在制备治疗糖尿病药物中的应用 A composition for the manufacture of a medicament for the treatment of diabetes |
| 01/14/2015 | CN104274442A 癌症的治疗 Treatment of cancer |
| 01/14/2015 | CN103861107B 一种药物组合物及其用途 A pharmaceutical composition and use thereof |
| 01/14/2015 | CN103172819B 侧链带有氨基的可生物降解聚氨酯及其制备方法和用途 Bio-degradable polyurethane amino side chains with their preparation and use |
| 01/14/2015 | CN102834115B 用于治疗流感的重组人cc10蛋白 Recombinant human proteins for the treatment of influenza cc10 |
| 01/14/2015 | CN102743755B 预防中风复发的组合物 Prevention of stroke recurrence composition |
| 01/14/2015 | CN102089001B 免疫诱导剂及癌的检测方法 Detection of immune-induced cancer agents |
| 01/14/2015 | CN101212986B 稳定的乳化组合物 Stable emulsified composition |
| 01/13/2015 | US8933255 Nutraceuticals containing nitro fatty acids |
| 01/13/2015 | US8933233 1,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitors |
| 01/13/2015 | US8933232 1,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitors |
| 01/13/2015 | US8933213 Antisense modulation of fibroblast growth factor receptor 4 expression |
| 01/13/2015 | US8933211 Growth factor isoform |
| 01/13/2015 | US8933202 AXL antibodies |
| 01/13/2015 | US8933199 Fibronectin based scaffold domain proteins that bind to myostatin |
| 01/13/2015 | US8933119 Method for treating phytophotodermatitis |
| 01/13/2015 | US8933116 Gamma secretase inhibitors |
| 01/13/2015 | US8933113 Mineralocorticoid receptor antagonists |
| 01/13/2015 | US8933111 Crystalline form of (2S,4R)-5-biphenyl-4-yl-2-hydroxymethyl-2-methyl-4-[(1H-[1,2,3]triazole-4-carbonyl)-amino]-pentanoic acid 5-methyl-2-oxo-[1,3]dioxol-4-ylmethyl ester |
| 01/13/2015 | US8933110 Hepatitis C virus inhibitors |
| 01/13/2015 | US8933108 Benzothiazolone compound |
| 01/13/2015 | US8933102 Pyrrolidine derived β3 adrenergic receptor agonists |
| 01/13/2015 | US8933092 Methods and compositions comprising sequential administration opioid receptor agonists |
| 01/13/2015 | US8933091 Method of inhibiting C-KIT kinase |
| 01/13/2015 | US8933086 Heteroaryl substituted pyrrolo[2,3-B]pyridines and pyrrolo[2,3-B]pyrimidines as Janus kinase inhibitors |
| 01/13/2015 | US8933078 Method of treating cancer with combinations of histone deacetylase inhibitors (HDAC1) substances |
| 01/13/2015 | US8933066 Compounds for the treatment of hepatitis C |
| 01/13/2015 | US8933056 Soft protease inhibitors and pro-soft forms thereof |
| 01/13/2015 | US8933053 Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancer |
| 01/13/2015 | US8933046 Influenza targets |
| 01/13/2015 | US8933044 RNA interference mediating small RNA molecules |
| 01/13/2015 | US8933037 Methods involving PDGFRBETA inhibitors |
| 01/13/2015 | US8933034 Chimeric neuregulins and method of making and use thereof |
| 01/13/2015 | US8933030 Treatments for gastrointestinal disorders |
| 01/13/2015 | US8933029 Antimicrobial and anti-inflammatory peptides |
| 01/13/2015 | US8933028 Use of selective estrogen receptor modulator for joint fusion and other repair or healing of connective tissue |
| 01/13/2015 | US8933015 Macrocyclic inhibitors of flaviviridae viruses |
| 01/13/2015 | US8933013 Co-administration of an agent linked to an internalization peptide with an anti-inflammatory |
| 01/13/2015 | US8933011 Treatment of preterm labor with toll-like receptor 9 antagonists |
| 01/13/2015 | US8932829 Recombinant alpha-fetoprotein and compositions thereof |
| 01/13/2015 | US8932806 Method for identifying t-cell stimulating protein fragments |
| 01/13/2015 | US8932649 Methods for treating a neoplastic disease in a subject using inorganic selenium-containing compounds |
| 01/13/2015 | US8932630 Opioid agonist/antagonist combinations |
| 01/13/2015 | US8932610 Aqueous clear solutions of fluocinolone acetonide for treatment of otic inflammation |
| 01/13/2015 | US8932609 Flagellin related polypeptides and uses thereof |
| 01/13/2015 | US8932594 Adjuvants and methods of use |
| 01/13/2015 | US8932575 Compositions and methods for inducing migration by dendritic cells and an immune response |
| 01/13/2015 | CA2540666C Glucocerebroside treatment of disease |
| 01/13/2015 | CA2498777C Non-sequence complementary antiviral oligonucleotides |
| 01/13/2015 | CA2436469C Composition for heart disease, method to prepare same and uses thereof |
| 01/08/2015 | WO2015003128A1 Reducing adverse side effects of a compound by a neurotoxin |
| 01/08/2015 | WO2015003122A2 Regulation of glucose metabolism using anti-cgrp antibodies |
| 01/08/2015 | WO2015002952A1 Methods for treating hcv |
| 01/08/2015 | WO2015002293A1 Wnt SIGNAL INHIBITOR |
| 01/08/2015 | WO2015001349A1 Methods and compounds for preventing osteoarthritis |
| 01/08/2015 | WO2015000921A1 Ptgds pathway activators and use in pathologies characterized by altered myelination in the cns |
| 01/08/2015 | WO2015000800A1 Pharmacological stimulation to facilitate and restore standing and walking functions in spinal cord motor disorders |
| 01/08/2015 | US20150011864 Prevention of Mild Cognitive Impairment and Eventual Alzheimer's Disease |
| 01/08/2015 | US20150011641 High load dispersions |
| 01/08/2015 | US20150011630 Dihydroxyphenyl neurotransmitter compounds, compositions and methods |
| 01/08/2015 | US20150011611 Inhibition of the glycine cleavage system for treatment of cancer |
| 01/08/2015 | US20150011610 Method for enhancing remyelination using gli1 inhibitors |
| 01/08/2015 | US20150011569 NOVEL P13K p110 INHIBITORS AND METHODS OF USE THEREOF |
| 01/08/2015 | US20150011542 Methods of Treating Adverse Intestinal Effects of Non-Steroidal Anti-Inflammatory Drugs |
| 01/08/2015 | US20150011541 Pipecolate-sulfonamides for treatment of psychiatric disorders |
| 01/08/2015 | US20150011535 Heterocyclic compounds, medicaments containing them, use and processes for the preparation thereof |
| 01/08/2015 | US20150011531 Inhibitors of hiv replication |
| 01/08/2015 | US20150011522 Compounds and compositions for the treatment of parasitic diseases |
| 01/08/2015 | US20150011517 Lupane triterpenoid derivatives and pharmaceutical use thereof |
| 01/08/2015 | US20150011516 Pharmaceutical compositions which inhibit fkbp52-mediated regulation of androgen receptor function and methods of using same |
| 01/08/2015 | US20150011514 Celecoxib Compositions |
| 01/08/2015 | US20150011510 Substituted 4-phenyl-pyridines |
| 01/08/2015 | US20150011502 Methods and compositions to treat myocardial conditions |
| 01/08/2015 | US20150011500 Compositions Prepared From Poultry And Methods Of Their Use |
| 01/08/2015 | US20150011496 Methods and compositions for stimulating bone regeneration |
| 01/08/2015 | US20150011494 Therapeutic curcumin derivatives |
| 01/08/2015 | US20150011488 Antiviral epicatechins, epicatechin oligomers, or thiolated epicatechins from theobroma cacao for treatment of genital warts |
| 01/08/2015 | US20150011470 N1-PYRAZOLOSPIROKETONE ACETYL-CoA CARBOXYLASE INHIBITORS |
| 01/08/2015 | US20150011461 Heteroaryl pyridone and aza-pyridone amide compounds |
| 01/08/2015 | US20150011460 Alpha 1-proteinase inhibitor for delaying the onset or progression of pulmonary exacerbations |
| 01/08/2015 | US20150010665 Medicament Containing Taraxacum Plant Root Extract for Treatment or Prevention of Cancer, and Method for Preparing Same |
| 01/08/2015 | US20150010654 Methods and Compositions for Treating Mucosal Tissue Disorders |
| 01/08/2015 | US20150010647 Methods for Identifying Fragile Histidine Triad (FHIT) Interaction and Uses Thereof |
| 01/08/2015 | US20150010643 Methods, pharmaceutical compositions, therapeutic systems, and compounds for treating b cell malignancies |
| 01/08/2015 | US20150010640 Bi-functional compositions for targeting cells to diseased tissues and methods of using same |
| 01/08/2015 | US20150010627 New pharmaceutical compositions of flurbiprofen and glucosamin |
| 01/08/2015 | US20150010623 Controlled release preparations |
| 01/08/2015 | US20150010617 Inhalable liquid formulations of dnase i |
| 01/08/2015 | US20150010599 Pharmaceutical formulation for reducing bladder spasms and method of use thereof |
| 01/08/2015 | US20150010586 p53 Peptide Vaccine |
| 01/08/2015 | US20150010585 Immunoconjugates targeting syndecan-1 expressing cells and use thereof |
| 01/08/2015 | US20150010582 Use of pdgfr-alpha as diagnostic marker for papillary thyroid cancer |
| 01/08/2015 | US20150010576 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 01/08/2015 | US20150010575 Combination therapy for the treatment of cancer using an anti-c-met antibody |
| 01/08/2015 | US20150010574 Anti-igf antibodies |
| 01/08/2015 | US20150010570 Methods and compositions for using mhc class ii invariant chain polypeptides as a receptor for macrophage migration inhibitory factor |
| 01/08/2015 | US20150010563 Methods for Treating Corneal and Conjunctival Inflammation and Inflammatory Disorders |
| 01/08/2015 | US20150010562 Pulmonary hypertension |